AIMC Topic: Drug Discovery

Clear Filters Showing 121 to 130 of 1689 articles

Machine learning analysis of molecular dynamics properties influencing drug solubility.

Scientific reports
Solubility is critical in drug discovery and development, as it significantly influences a medication's bioavailability and therapeutic efficacy. Understanding solubility at the early stages of drug discovery is essential for minimizing resource cons...

DTIP-WINDGRU a novel drug-target interaction prediction with wind-enhanced gated recurrent unit.

BMC bioinformatics
BACKGROUND: Identification of drug target interactions (DTI) is an important part of the drug discovery process. Since prediction of DTI using laboratory tests is time consuming and laborious, automated tools using computational intelligence (CI) tec...

AI-Empowered Molecular Editing Opens a New Horizon in Pesticide Discovery.

Journal of agricultural and food chemistry
Rapid evolution of digital technologies has enabled vital tools in pesticide discovery, which are crucial for agricultural productivity and food security. Therein, molecular editors have emerged as basic and critical tools in this field. However, exi...

A hybrid framework of generative deep learning for antiviral peptide discovery.

Scientific reports
Antiviral peptides (AVPs) hold great potential for combating viral infections, yet their discovery and development remain challenging. In this study, we present a hybrid model combining Wasserstein Generative Adversarial Networks with Gradient Penalt...

Machine Learning-Assisted Iterative Screening for Efficient Detection of Drug Discovery Starting Points.

Journal of medicinal chemistry
High-throughput screening (HTS) remains central to small molecule lead discovery, but increasing assay complexity challenges the screening of large compound libraries. While retrospective studies have assessed active-learning-guided screening, extens...

ML enhanced bioactivity prediction for angiotensin II receptor: A potential anti-hypertensive drug target.

Scientific reports
The process of drug discovery is intricate, and encompasses a series of detailed phases of research, development, and testing, aimed at evaluating the safety and effectiveness of prospective therapeutic agents. Artificial Intelligence has emerged as ...

Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence.

Nature communications
The rise of antibiotic-resistant pathogens, particularly gram-negative bacteria, highlights the urgent need for novel therapeutics. Drug-resistant infections now contribute to approximately 5 million deaths annually, yet traditional antibiotic discov...

Deep homo-heterogeneous association mining with hybrid scholars and multidimensional mixed moment networks: Embedding-Driven prediction of microbe-drug interactions.

Computers in biology and medicine
Drug repurposing accelerates microbial therapy development by bypassing the costly and time-consuming traditional drug discovery process. However, existing computational methods for predicting drug-microbe associations (MDAs) struggle to capture comp...

Machine-Learning-Driven Discovery of -Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhibition with Anti-Pancreatic Cancer Activity.

Journal of medicinal chemistry
Lactate dehydrogenase A (LDHA) is a promising target for cancer therapy due to its crucial role in aerobic glycolysis. Despite extensive efforts, the structural diversity of LDHA inhibitors remains limited. Here, we utilized machine learning techniqu...

Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey.

Journal of chemical information and modeling
In recent years, generative deep learning has emerged as a transformative approach in drug design, promising to explore the vast chemical space and generate novel molecules with desired biological properties. This perspective examines the challenges ...